Sponsored Seminars

Medical Seminar
Evening Seminar
Morning Seminar

Medical Seminar

Medical Seminar1

MeS1
Cancer Genomic Medicine guided by CGP testing

March 6 (Thu)12:00–12:50
Room2 (Kobe Portopia Hotel, South Wing 1F Ohwada A)

Chair	Hiroshi Nishihara	(Center for Cancer Genomics, Keio University School of Medicine)
Speaker	Clinical significance of CGP testing in the pancreas
	Chigusa Morizane	(Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital)
	Cancer Genomic Medicine guided by CGP testing - Tumor agnostic -
	Yoichi Naito	(Department of General Internal Medicine, National Cancer Center Hospital East )
Co-host	CHUGAI PHARMACEUTICAL CO., LTD.

Medical Seminar2

MeS2
Beyond the knife: Towards the Era of Tumor-agnostic MRD Testing

March 6 (Thu)12:00–12:50
Room3 (Kobe Portopia Hotel, South Wing 1F Ohwada B)

Chair	Eishi Baba	(Department of Comprehensive Oncology, Graduate School of Medical Sciences, Kyushu University)
Speaker	Yoshiaki Nakamura	(International Research Promotion Office, Department of Gastrointestinal Oncology, Translational Research Support Office, National Cancer Center Hospital East)
Co-host	Myriad Genetics G.K. /SRL, Inc.

Medical Seminar3

MeS3
Patients-centered treatment for EGFR mutation-positive lung cancer

March 6 (Thu)12:00–12:50
Room4 (Kobe Portopia Hotel, South Wing 1F Ohwada C)

Discussant
Chair	Kazuhiko Nakagawa	(Kindai University Faculty of Medicine)
Speaker	Takashi Seto	(National Hospital Organization Kyushu Cancer Center)
	Hiroshige Yoshioka	(Kansai Medical University )
	Kazuo Hasegawa	(NPO Lung Cancer Patients Association One Step, Kanagawa.)
Co-host	Eli Lilly Japan K.K.

Medical Seminar4

MeS4
The role of biomarkers in gastric and colon cancer treatment and future prospects

March 6 (Thu)12:00–12:50
Room5 (Kobe Portopia Hotel, South Wing B1F Topaz)

Chair	Kei Muro	(Aichi Cancer Center)
Speaker	Filippo Pietrantonio	(Fondazione IRCCS Istituto Nazionale dei Tumori di Milano)
Co-host	Amgen K.K. Medical Department

Medical Seminar5

MeS5
Present and future perspective on clinical practice for hereditary cancers. -The insights from SCRUM-Japan MONSTAR-SCREEN initiative-

March 6 (Thu)12:00–12:50
Room6 (Kobe Portopia Hotel, South Wing B1F Emerald)

Chair	Issei Imoto	(Aichi Cancer Center, Research Institute)
Speaker	Takeshi Kuwata	(Department of Genetic Medicine and Services, National Cancer Center Hospital East)
Co-host	Myriad Genetics G.K. /SRL, Inc.

Medical Seminar6

MeS6
Fruquintinib: Redefining Late-line Options for Colorectal Cancer

March 6 (Thu)12:00–12:50
Room7 (Kobe International Conference Center, B1/1F Main Hall)

Chair	Takayuki Yoshino	(National Cancer Center Hospital East)
Speaker	Hisato Kawakami	(Tohoku University Hospital)
Co-host	Takeda Pharmaceutical Company Limited

Medical Seminar7

MeS7
Leading-edge treatment strategies for HER2 negative advanced gastric cancer

March 6 (Thu)12:00–12:50
Room8 (Kobe International Conference Center, 3F International Conference Room)

Chair	Daisuke Takahari	(Department of Medical Oncology, Gunma University Graduate School of Medicine)
Speaker	Zev A. Wainberg	(Medicine at the University of California, Los Angeles (UCLA))
Co-host	MSD K.K.

Medical Seminar8

MeS8
Optimal Treatment for MSI-H Colorectal Cancer

March 6 (Thu)12:00–12:50
Room9 (Kobe International Conference Center, 4F 401+402)

Chair	Yu Sunakawa	(Department of Clinical Oncology, St. Marianna University School of Medicine)
Speaker	Daisuke Kotani	(Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East)
Co-host	Bristol-Myers Squibb K.K. /ONO PHARMACEUTICAL CO., LTD.

Medical Seminar9

MeS9
Implementation of Immunotherapy in Biliary Tract Cancer

March 6 (Thu)12:00–12:50
Room10 (Kobe International Conference Center, 5F 501)

Chair	Masafumi Ikeda	( National Cancer Center Hospital East)
Speaker	Do-Youn Oh	(Division of Medical Oncology, Department of Internal Medicine, Seoul National University Hospital Cancer Research Institute, Seoul National University College of Medicine, Korea)
Co-host	AstraZeneca K.K.

Medical Seminar10

MeS10
TREATMENT LANDSCAPE IN CERVICAL CANCER: CURRENT STATUS AND FUTURE DIRECTIONS

March 6 (Thu)12:00–12:50
Room11 (Kobe International Conference Center, 5F 502)

Chair	Kan Yonemori	(Department of Medical Oncology, National Cancer Center Hospital)
Speaker	Jung-Yun Lee	(Yonsei Cancer Center and Severance Hospital, Yonsei University College of Medicine, Seoul)
Co-host	MSD K.K.

Medical Seminar11

MeS11
Revolutionizing Gynecologic Cancer Treatment: Current Landscape and Future Horizons

March 6 (Thu)12:00–12:50
Room12 (Kobe International Conference Center, 5F 504+505)

Chair	Kosei Hasegawa	(Saitama Medical University International Medical Center)
Speaker	Kathleen N Moore	(Stephenson Oklahoma Cancer Center at the University of Oklahoma )
Co-host	Takeda Pharmaceutical Company Limited Medical Affairs

Medical Seminar12

MeS12
Combination strategies for the treatment of advanced and recurrent endometrial cancer

March 6 (Thu)12:00–12:50
Room13 (Kobe International Exhibition Hall, No.2 2F 2A Meeting Room)

Chair	Aikou Okamoto	(Department of Obstetrics and Gynecology, The Jikei University School of Medicine)
Speaker	Shannon Neville Westin	(Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery, The University of Texas MD Anderson Cancer Center)
Co-host	AstraZeneca K.K.

Medical Seminar13

MeS13
New biomarker based treatment strategies for metastatic gastric cancer

March 6 (Thu)12:00–12:50
Room14 (Kobe International Exhibition Hall, No.2 3F 3A Meeting Room)

Chair	Narikazu Boku	(University of Tokyo Hospital)
Speaker	Sun Young Rha	(Yonsei Cancer Center, Yonsei university College of Medicine)
Co-host	Astellas Pharma Inc.

Medical Seminar14

MeS14
Treatment strategy up to date for HER2 negative Gastric Cancer

March 7 (Fri)11:35–12:25
Room2 (Kobe Portopia Hotel, South Wing 1F Ohwada A)

Chair	Kensei Yamaguchi	(Cancer Institute Hospital of Japanese Foundation for Cancer Research )
Speaker	Mistakes in choosing first line treatment for HER2-negative advanced gastric cancer
	Kei Muro	(Aichi Cancer Center Hospital)
Co-host	Bristol-Myers Squibb K.K. /ONO PHARMACEUTICAL CO., LTD.

Medical Seminar15

MeS15
Update on Trastuzumab Deruxtecan for the Management of HER2-Expressing Metastatic Breast Cancer.

March 7 (Fri)11:35–12:25
Room4 (Kobe Portopia Hotel, South Wing 1F Ohwada C)

Chair	Shigehira Saji	(Department of Medical Oncology, Fukushima Medical University, School of Medicine)
Speaker	Shanu Modi	(HER2 Breast Cancer Program Breast Medicine Service, Department of Medicine Memorial Sloan Kettering Cancer Center)
Co-host	DAIICHI SANKYO COMPANY, LIMITED

Medical Seminar16

MeS16
New standard of care for unresectable biliary tract cancer: Combination chemo-immunotherapy based on phase III trial data

March 7 (Fri)11:35–12:25
Room5 (Kobe Portopia Hotel, South Wing B1F Topaz)

Chair	Masafumi Ikeda	(Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East)
Speaker	Robin Kate Kelley	(Division of Hematology and Oncology, University of California, San Francisco)
Co-host	MSD K.K.

Medical Seminar17

MeS17
Systemic therapy for Advanced Thyroid Cancer: Recent Advances and Challenges

March 7 (Fri)11:35–12:25
Room6 (Kobe Portopia Hotel, South Wing B1F Emerald)

Chair	Shunji Takahashi	(Cancer Institute Hospital of JFCR Department of Genomic Medicine)
Speaker	Naomi Kiyota	(Kobe University Hospital Cancer Center)
Co-host	ONO PHARMACEUTICAL CO., LTD.

Medical Seminar18

MeS18
How should we treat patients with EGFR mutation ?

March 7 (Fri)11:35–12:25
Room7 (Kobe International Conference Center, B1/1F Main Hall)

Chair	Yukari Tsubata	(Department of Respirology, Graduate School of Medicine, Gifu University)
Speaker	Solange Peters	(Medical Oncology, Lausanne University Hospital(CHUV), Lausanne, Switzerland)
Co-host	AstraZeneca K.K.

Medical Seminar19

MeS19
Recent Advances in the Management of Triple-Negative Breast Cancer

March 7 (Fri)11:35–12:25
Room8 (Kobe International Conference Center, 3F International Conference Room)

Chair	Yoichi Naito	(Department of General Internal Medicine, National Cancer Center Hospital East)
Speaker	Sung-Bae Kim	(Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Korea)
Co-host	MSD K.K.

Medical Seminar20

MeS20
Treatment Strategies for EGFR Mutation-Positive Lung Cancer : Aiming for Optimal Patient Care

March 7 (Fri)11:35–12:25
Room9 (Kobe International Conference Center, 4F 401+402)

Chair	Hidetoshi Hayashi	(Kindai University)
Speaker	Kentaro Ito	(Matsusaka Municipal Hospital)
	Shuji Murakami	(Kanagawa Cancer Center)
Co-host	Eli Lilly Japan K.K.

Medical Seminar21

MeS21
HER2DX: Redefining Treatment Strategies in HER2-Positive Breast Cancer

March 7 (Fri)11:35–12:25
Room10 (Kobe International Conference Center, 5F 501)

Chair	Shigenori Nagai	(Saitama Cancer Center Division of Breast Oncology)
Speaker	Aleix Prat	(Clinic Barcelona Comprehensive Cancer Center, Barcelona, Spain)
Co-host	CHUGAI PHARMACEUTICAL CO., LTD.

Medical Seminar22

MeS22
IO-based Perioperative Therapies in NSCLC: Evolving Our Mindsets as We Strive to Cure

March 7 (Fri)11:35–12:25
Room11 (Kobe International Conference Center, 5F 502)

Chair	Nobuyuki Yamamoto	(Internal Medicine III, Wakayama Medical University)
Speaker	Terufumi Kato	(Department of Thoracic Oncology, Kanagawa Cancer Center)
Co-host	MSD K.K.

Medical Seminar23

MeS23
The Frontline of HER2-Targeted Therapy for Gastric Cancer

March 7 (Fri)11:35–12:25
Room12 (Kobe International Conference Center, 5F 504+505)

Chair	Narikazu Boku	(Department of Oncology and General Medicine, IMSUT Hospital, Institute of Medical Science, University of Tokyo)
Speaker	Tomohiro Nishina	(NHO Shikoku Cancer center, Department of Cancer Genomic Medicine)
Co-host	DAIICHI SANKYO COMPANY, LIMITED

Medical Seminar24

MeS24
New Treatment Strategies for Metastatic Urothelial Carcinoma

March 7 (Fri)11:35–12:25
Room13 (Kobe International Exhibition Hall, No.2 2F 2A Meeting Room)

Chair	Hiroshi Kitamura	(Department of Urology, Faculty of Medicine, University of Toyama, JAPAN )
Speaker	Axel S. Merseburger	(University Hospital Schleswig-Holstein Lübeck, Germany)
Co-host	MSD K.K.

Medical Seminar25

MeS25
Targeting actionable mutations to overcome endocrine resistance with liquid biopsies

March 7 (Fri)11:35–12:25
Room14 (Kobe International Exhibition Hall, No.2 3F 3A Meeting Room)

Chair	Tatsunori Shimoi	(Department of Medical Oncology, National Cancer Center Hospital)
Speaker	François-Clément Bidard	(Institut Curie)
Co-host	AstraZeneca K.K.

Medical Seminar26

MeS26
Advances in the treatment strategy of la/mUC

March 8 (Sat)12:00–12:50
Room2 (Kobe Portopia Hotel, South Wing 1F Ohwada A)

Chair	Norio Nonomura	(Department of Urology, Osaka University Graduate School of Medicine)
Speaker	Thomas Powles	(University of London/Barts Cancer Centre)
Co-host	Astellas Pharma Inc.

Medical Seminar27

MeS27
Advances in Personalized Medicine for Breast Cancer: Focusing on the MyChoice Diagnostic System

March 8 (Sat)12:00–12:50
Room3 (Kobe Portopia Hotel, South Wing 1F Ohwada B)

Chair	Takanori Ishida	(Tohoku University School of medicine, Breast and Endocrine Surgical Oncology)
Speaker	Yutaka Yamamoto	(Kumamoto University Hospital, Breast and Endocrine Surgery)
Co-host	Myriad Genetics G.K. /SRL, Inc.

Medical Seminar28

MeS28
The significance and positioning of the COVID-19 vaccine for specialists involved in cancer treatment.

March 8 (Sat)12:00–12:50
Room4 (Kobe Portopia Hotel, South Wing 1F Ohwada C)

Chair	Naomi Kiyota	(Kobe University Graduate School of Medicine)
Speaker	Significance of COVID-19 Vaccination for Cancer Patients
	Shigeru Suga	(National Hospital Organization Mie National Hospital)
	Effectiveness of COVID-19 Vaccine in Cancer Patients
	Keiji Okinaka	(Department of Infectious Diseases, National Cancer Center Hospital East, Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital)
Co-host	Pfizer Japan Inc, Medical Affairs

Medical Seminar29

MeS29
Tumor immunity and inhibition of angiogenesis

March 8 (Sat)12:00–12:50
Room5 (Kobe Portopia Hotel, South Wing B1F Topaz)

Chair	Makoto Nishio	(Department of Thoracic Medical Oncology, Cancer Institute Hospital , Japanese Foundation for Cancer Research)
Speaker	Tumor microenvironment and immuno-oncology
	Yosuke Togashi	(Department of Tumor Microenvironment, Faculty of Medicine, Dentistry and Pharmaceutical Sciences (Medicine) OKAYAMA UNIVERSITY HOSPITAL, Department of Allergy and Respiratory Medicine )
	The importance of the significance of concomitant use of VEGF inhibitors and ICIs
	Naoyuki Nogami	(Department of Community Medicine, Pulmonology and Cardiology Ehime University Graduate School of Medicine)
Co-host	CHUGAI PHARMACEUTICAL CO., LTD.

Medical Seminar30

MeS30
Latest Insights in Translational Research for Small Cell Lung Cancer Treatment Development

March 8 (Sat)12:00–12:50
Room6 (Kobe Portopia Hotel, South Wing B1F Emerald)

Chair	Koichi Goto	(National Cancer Center Hospital East)
Speaker	Tatsuya Yoshida	(National Cancer Center Hospital)
Co-host	Amgen K.K. Medical Department

Medical Seminar31

MeS31
Global standard in HR(+) HER2(-) advanced recurrent breast cancer

March 8 (Sat)12:00–12:50
Room7 (Kobe International Conference Center, B1/1F Main Hall)

Chair	Junichiro Watanabe	(Department of Breast Oncology, Juntendo University Graduate School of Medicine)
Speaker	Carlos Barrios	(LACOG and Oncology Research Center at Hospital São Lucas-PUCRS)
Co-host	Eli Lilly Japan K.K.

Medical Seminar32

MeS32
Advances in r/rDLBCL Treatment and Unmet Medical Needs

March 8 (Sat)12:00–12:50
Room8 (Kobe International Conference Center, 3F International Conference Room)

Chair	Yosuke Minami	(Department of Hematology, National Cancer Center Hospital East)
Speaker	Grzegorz Stanislaw Nowakowski	(Mayo Clinic, USA)
Co-host	Genmab KK, Medical Affairs / AbbVie GK, Medical

Medical Seminar33

MeS33
Changes in AML treatment strategies-Focusing on FLT3 Inhibitors-

March 8 (Sat)12:00–12:50
Room9 (Kobe International Conference Center, 4F 401+402)

Chair	Hitoshi Kiyoi	(Department of Hematology and Oncology, Nagoya University Graduate School of Medicine)
Speaker	Takahiro Yamauchi	(Department of Hematology and Oncology, University of Fukui)
Co-host	Astellas Pharma Inc.

Medical Seminar34

MeS34
Evolving treatment landscape for EGFR exon20 insertion NSCLC

March 8 (Sat)12:00–12:50
Room10 (Kobe International Conference Center, 5F 501)

Chair	Hidetoshi Hayashi	(Faculty of Medicine Department of Medical Oncology, Kindai University)
Speaker	Byoung Chul Cho	(Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine)
Co-host	Johnson & Johnson

Medical Seminar35

MeS35
Advancing Precision Oncology: Caris's Innovative Technologies and Clinical Impact in Japan

March 8 (Sat)12:00–12:50
Room11 (Kobe International Conference Center, 5F 502)

Chair	Takayuki Yoshino	(National Cancer Center Hospital East)
Speaker	Matthew Oberley	(Caris Life Sciences)
	Insights from MONSTAR-SCREEN - The Clinical Impact of WES/WTS and CHIP Analyses -
	Mitsuho Imai	(National Cancer Center Hospital East)
Co-host	Caris K.K.

Medical Seminar36

MeS36
Key points of gastric cancer chemotherapy to keep in mind now ~Evidence & Practice~

March 8 (Sat)12:00–12:50
Room12 (Kobe International Conference Center, 5F 504+505)

Chair	Kensei Yamaguchi	(Department of Gastroenterological Chemotherapy, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research)
Speaker	Yu Sunakawa	(Department of Clinical Oncology, St. Marianna University School of Medicine)
	Toshihiko Matsumoto	(Department of Medical Oncology, Ichinomiyanishi Hospital)
Co-host	Eli Lilly Japan K.K.

Medical Seminar37

MeS37
Treatment Strategy & Practice for Unresectable Pancreatic Cancer

March 8 (Sat)12:00–12:50
Room13 (Kobe International Exhibition Hall, No.2 2F 2A Meeting Room)

Chair	Makoto Ueno	(Department of Gastroenterology Kanagawa Cancer Center)
Speaker	Teresa Macarulla	(Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Spain)
Co-host	Nihon Servier Co., Ltd.

Medical Seminar38

MeS38
Optimal central venous device selection for chemotherapy

March 8 (Sat)12:00–12:50
Room14 (Kobe International Exhibition Hall, No.2 3F 3A Meeting Room)

Chair	Kei Muro	(Aichi Cancer Center)
Speaker	Based on international experts consensus
	Kei Muro	(Aichi Cancer Center)
	Guidelines for the management of the chemotherapy extravasation
	Koji Matsumoto	(Hyogo Cancer Center)
Co-host	Medicon

Evening Seminar

Evening Seminar1

ES1
Treatment Strategies for ALK-Positive Lung Cancer

March 6 (Thu)17:50–18:40
Room2 (Kobe Portopia Hotel, South Wing 1F Ohwada A)

Chair	Isamu Okamoto	(Department of Respiratory Medicine, Graduate School of Medical Sciences, Kyushu University)
Speaker	Treatment Sequence for advanced ALK-positive non-small cell lung cancer
	Kazushige Wakuda	(Division of Thoracic Oncology, Shizuoka Cancer Center)
	First-line treatment for advanced ALK-positive non-small cell lung cancer
	Kohei Otsubo	(Department of Respiratory Medicine, Graduate School of Medical Sciences, Kyushu University)
Co-host	Takeda Pharmaceutical Company Limited

Evening Seminar2

ES2
Thyroid Cancer Update in South Korea and Japan

March 6 (Thu)17:50–18:40
Room3 (Kobe Portopia Hotel, South Wing 1F Ohwada B)

Chair	Susumu Okano	(Department of Head and Neck Medical Oncology, National Cancer Center Hospital East)
Speaker	Current status, Issues and Future Prospects of Genomics Medicine for Thyroid Cancer in South Korea
	Bhumsuk Keam	(Department of Internal Medicine, Seoul National University Hospital)
	Current status, Issues and Future Prospects of Genomics Medicine for Thyroid Cancer in Japan
	Makoto Tahara	(Department of Head and Neck Medical Oncology, National Cancer Center Hospital East)
Co-host	Novartis Pharma K.K.

Evening Seminar3

ES3
The Latest Treatment Strarategy in Lung Cancer ~Diagnosis and Therapy for Patient’s Life~

March 6 (Thu)17:50–18:40
Room4 (Kobe Portopia Hotel, South Wing 1F Ohwada C)

Chair	Miyako Satouchi	(Hyogo Cancer Center Department of Respiratory Medicine)
Speaker	Genetic Testing in Non-Small Cell Lung Cancer ~To close encounters of the Rare mutations~
	Tomohiro Sakamoto	(Division of Respiratory Medicine and Rheumatology, Department of Multidisciplinary Internal Medicine, Faculty of Medicine, Tottori University)
	Close Encounters of the Rare mutations ~Focus on MET~
	Yuko Oya	(Department of Respiratory Medicine, Fujita Health University School of Medicine)
Co-host	TAIHO PHARMACEUTICAL CO., LTD.

Evening Seminar4

ES4
Latest Clinical Evidence & Future Outlook in NSCLC treatment

March 6 (Thu)17:50–18:40
Room5 (Kobe Portopia Hotel, South Wing B1F Topaz)

Chair	Satoshi Oizumi	(Department of Respiratory Medicine, NHO Hokkaido Cancer Center)
Speaker	Nobuhiko Seki	(Division of Medical Oncology, Department of Internal Medicine, Teikyo University School of Medicine)
Co-host	MSD K.K.

Evening Seminar5

ES5
Shifting the Focus: Financial and Time Toxicity in Cancer Care

March 6 (Thu)17:50–18:40
Room6 (Kobe Portopia Hotel, South Wing B1F Emerald)

Chair	Hidetoshi Hayashi	(Department of Medical Oncology, Kindai University)
Speaker	Financial and Time toxicity of cancer
	Kazunori Honda	(Department of Clinical Oncology, Aichi Cancer Center)
	How to evaluate the value of reducing time toxicity in cancer chemotherapy
	Tsubasa Tamura	(Department of Nursing, Hiroshima Prefectural Hospital)
Co-host	Kyowa Kirin Co Ltd

Evening Seminar6

ES6
Treatment strategies for non-small cell lung cancer from clinical and statistical interpretations

March 6 (Thu)17:50–18:40
Room7 (Kobe International Conference Center, B1/1F Main Hall)

Chair	Seiji Yano	(Department of Respiratory Medicine, Graduate School of Medical Sciences, Kanazawa University)
Speaker	Treatment strategy of ALK-positive NSCLC using Alectinib
	Hidehito Horinouchi	(Department of Thoracic Oncology, National Cancer Center Hospital)
	Unveiling PFS and OS in Advanced Lung Cancer Clinical Trials from Medical Statistics
	Satoshi Morita	(Department of Biomedical Statistics and Bioinformatics, Kyoto University Graduate School of Medicine)
Co-host	CHUGAI PHARMACEUTICAL CO., LTD.

Evening Seminar7

ES7
Treatment strategy for esophageal cancer in 1st line setting for long survival

March 6 (Thu)17:50–18:40
Room8 (Kobe International Conference Center, 3F International Conference Room)

Chair	Keisho Chin	(Department of Outpatient Chemotherapy, Cancer Institute Hospital of JFCR)
Speaker	Daisuke Kotani	(Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East)
Co-host	MSD K.K.

Evening Seminar8

ES8
Perspectives of new treatment strategies in soft tissue sarcoma

March 6 (Thu)17:50–18:40
Room9 (Kobe International Conference Center, 4F 401+402)

Chair	Masanobu Takahashi	(Department of Clinical Oncology, Tohoku University Graduate School of Medicine)
Speaker	Kan Yonemori	(Department of Medical Oncology, National Cancer Center Hospital)
Co-host	CHUGAI PHARMACEUTICAL CO., LTD.

Evening Seminar9

ES9
Cutting edge of Hepatocellular Carcinoma Treatment: Treatment Strategies based on Clinical trials and Real World Data

March 6 (Thu)17:50–18:40
Room10 (Kobe International Conference Center, 5F 501)

Chair	Masafumi Ikeda	(Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East)
Speaker	Integration of Clinical Trial and Real World Data ~ Optimal Treatment Strategy for Hepatocellular Carcinoma Guided by Data Originating in Japan ~
	Makoto Ueno	(Department of Gastroenterology Kanagawa Cancer Center)
	Latest treatment strategy on HCC at the era of cancer immunotherapy
	Stephen L. Chan	(Department of Clinical Oncology, The Chinese University of Hong Kong.)
Co-host	CHUGAI PHARMACEUTICAL CO., LTD.

Evening Seminar10

ES10
Personalized therapy for colorectal cancer ~Chemotherapy and supportive care for individual patients~

March 6 (Thu)17:50–18:40
Room11 (Kobe International Conference Center, 5F 502)

Chair	Kensei Yamaguchi	(Department of Gastroenterological Chemotherapy, Cancer Institute Hospital of Japanese Foundation for Cancer Research)
Speaker	Self-care support for skin symptoms: how to personalize considering patient adherence
	Chisato Nakamura	(St.Marianna University Hospital palliative care center)
	The Frontiers of Biomarker-Based Personalized Therapy for Colorectal Cancer
	Hiroya Taniguchi	(Department of Clinical Oncology, Aichi Cancer Center Hospital)
Co-host	Merck Biopharma Co., Ltd.

Evening Seminar11

ES11
Towards High-Quality Cancer Patient Support: Perspectives on disease understanding and treatment decisions from Both Patients and Healthcare Professionals

March 6 (Thu)17:50–18:40
Room12 (Kobe International Conference Center, 5F 504+505)

Chair	Jiichiro Sasaki	(Division of Clinical Oncology, Department of Comprehensive Medicine, Research and Development Center for New Medical Frontiers, Kitasato University School of Medicine )
Speaker	Yoshiyuki Kizawa	(Department of Palliative and Supportive Care, Institute of Medicine, University of Tsukuba)
Co-host	CHUGAI PHARMACEUTICAL CO., LTD.

Evening Seminar12

ES12
The new wave of ADC in metastatic Triple Negative Breast Cancer

March 6 (Thu)17:50–18:40
Room13 (Kobe International Exhibition Hall, No.2 2F 2A Meeting Room)

Chair	Toshimi Takano	(The Cancer Institute Hospital of JFCR)
Speaker	Guiseppe Curigliano	(Early Drug Development, European Institute of Oncology, Milan, Medical Oncology at University of Milano)
Co-host	Gilead Sciences K.K.

Evening Seminar13

ES13
ICI Treatments strategies in Advanced Lung Cancer for diverse groups of patients

March 6 (Thu)17:50–18:40
Room14 (Kobe International Exhibition Hall, No.2 3F 3A Meeting Room)

Chair	Seiji Niho	(Dokkyo Medical University School of Medicine )
Speaker	POSEIDON’s usefulness considered, through various factors including but not limited to PD-L1 expression
	Yoshitaka Zenke	(National Cancer Center Hospital East )
	CASPIAN’s usefulness considered, through evidence for various patient background
	Koichi Azuma	(Kurume University Hospital)
Co-host	AstraZeneca K.K.

Evening Seminar14

ES14
How should cost-effectiveness be considered when selecting antiemetic therapy?

March 7 (Fri)17:50–18:40
Room2 (Kobe Portopia Hotel, South Wing 1F Ohwada A)

Chair	Keisho Chin	(Department of Outpatient Chemotherapy, Cancer Institute Hospital of JFCR)
Speaker	Better CINV management for both patients and healthcare professionals : Effective use of NK1 receptor antagonists for gastrointestinal MEC
	Kenji Okita	(Department of Surgery, Otaru Ekisaikai Hospital)
	The significance of prophylactic antiemetic therapy in cancer pharmacotherapy : Considering cost-benefit
	Hiroshi Inano	(Department of Pharmacy, Kitasato University Hospital.)
Co-host	TAIHO PHARMACEUTICAL CO., LTD.

Evening Seminar15

ES15
“To seek.., Not to seek..?!” ~Meeting the needs of cancer treatment using Join~

March 7 (Fri)17:50–18:40
Room3 (Kobe Portopia Hotel, South Wing 1F Ohwada B)

Chair	Kan Yonemori	(National Cancer Center Hosptail)
Speaker	Information Needed at Regional Cancer Treatment Centers: Current Status and Challenges
	Mihoko Doi	(Hiroshima Prefectural Hospital)
	Strategy to Promote the Recruitment of Rare Fractions and Their Challenges
	Toshiyuki Tamai	(Eisai Co., Ltd. )
	Challenges in cancer care in Japan solved by doctor to doctor online consultation system: regional inequality and drug loss
	Shosuke Kita	(National Cancer Center Hosptail)
Co-host	Allm inc.

Evening Seminar16

ES16
Delivering the benefits of immune combination therapy to patients

March 7 (Fri)17:50–18:40
Room4 (Kobe Portopia Hotel, South Wing 1F Ohwada C)

Chair	Takayasu Kurata	(Department of Thoracic Oncology, Kansai Medical University)
Speaker	Motohiro Tamiya	(Department of Thoracic Oncology, Osaka International Cancer Institute)
Co-host	ONO PHARMACEUTICAL CO., LTD./Bristol-Myers SquibbK.K.

Evening Seminar17

ES17
Updating treatment strategy in ALK-positive NSCLC - 5 year follow up from the CROWN study -

March 7 (Fri)17:50–18:40
Room5 (Kobe Portopia Hotel, South Wing B1F Topaz)

Chair	Hidetoshi Hayashi	(Department of Medical Oncology, Kindai University Faculty of Medicine)
Speaker	Daniel SW Tan	(Department of Medical Oncology/Department of Clinical Trials & Epidemiological Sciences, National Cancer Centre Singapore)
Co-host	Pfizer Japan Inc.

Evening Seminar18

ES18
Multidisciplinary Care in Cancer Cachexia

March 7 (Fri)17:50–18:40
Room6 (Kobe Portopia Hotel, South Wing B1F Emerald)

Chair	Kazuhiro Nishikawa	(Cancer Treatment Center, Osaka Police Hospital, Osaka International Medical and Science Center)
Speaker	The Significance of Early Therapeutic Intervention in Cancer Cachexia
	Hiroshi Imamura	(Department of Gastroenterological Surgery, Toyonaka Municipal Hospital)
	The Role of Nurses in the Outpatient Chemotherapy Room at Our Hospital
	Mayumi Hata	(Outpatient Therapy Center, Toyonaka Municipal Hospital)
	The Role of Pharmacists in the Outpatient Chemotherapy Room at Our Hospital
	Makiko Hisada	(Outpatient Therapy Center, Toyonaka Municipal Hospital)
Co-host	ONO PHARMACEUTICAL CO., LTD.

Evening Seminar19

ES19
An opportunity to be informed about head and neck cancer treatment

March 7 (Fri)17:50–18:40
Room7 (Kobe International Conference Center, B1/1F Main Hall)

Chair	Naomi Kiyota	(Cancer Center, Kobe University Hospital)
Speaker	Issues and reality of the treatment of recurrent metastatic head and neck cancer - Role as an Oncologist
	Shogen Boku	(Department of Clinical Oncology, Kansai Medical University Hospital)
	Surging demand for medical oncologists in head and neck areas
	Yoshitaka Honma	(Department of Head and Neck, Esophageal Medical Oncology, National Cancer Center Hospital)
Co-host	MSD K.K.

Evening Seminar20

ES20
Establishing Medical and Multidisciplinary Collaboration to Support People Living with and beyond Cancer

March 7 (Fri)17:50–18:40
Room9 (Kobe International Conference Center, 4F 401+402)

Paneldiscussion
Chair	Chikako Shimizu	(Department of Breast and Medical Oncology and Comprehensive Cancer Center,National Center for Global Health and Medicine)
Speaker	Kenji Tamura	(Shimane University Hospital Innovative Cancer Center)
	Bradley J. Zebrack	(the University of Michigan Rogel Cancer Center)
	Kenji Tamura	(Shimane University Hospital Innovative Cancer Center)
	Bradley J. Zebrack
Co-host	Pfizer Japan Inc. Medical Affairs

Evening Seminar21

ES21
Chemotherapy for colorectal cancer -practice and recent topics

March 7 (Fri)17:50–18:40
Room10 (Kobe International Conference Center, 5F 501)

Chair	Akihito Tsuji	(Department of Clinical Oncology, Faculty of Medicine, Kagawa University )
Speaker	Kentaro Yamazaki	(Division of Gastrointestinal Oncology, Shizuoka Cancer Center)
Co-host	TAKATA Pharmaceutical Co.,Ltd.

Evening Seminar22

ES22
Revisiting the Treatment Strategies for Squamous Cell Lung Cancer –Positioning of Necitumumab–

March 7 (Fri)17:50–18:40
Room11 (Kobe International Conference Center, 5F 502)

Chair	Koichi Azuma	(Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine.)
Speaker	Hisashi Tanaka	(Department of Respiratory Medicine, Hirosaki University Graduate School of Medicine.)
	Hiroshige Yoshioka	(Department of Thoracic Oncology, Kansai Medical University Hospital.)
Co-host	Nippon Kayaku Co.,Ltd.

Evening Seminar23

ES23
Precision Medicine in Colorectal Cancer ~Organizing and Practicing the Evidence~

March 7 (Fri)17:50–18:40
Room12 (Kobe International Conference Center, 5F 504+505)

Chair	Taroh Satoh	(Center for Cancer Genomics and Precision Medicine, Osaka University Hospital)
Speaker	Hisato Kawakami	(Department of Clinical Oncology, Tohoku University Graduate School of Medicine)
Co-host	ONO PHARMACEUTICAL CO., LTD.

Evening Seminar24

ES24
EGFR Exon 20 Insertion Mutation Therapy and Skin Disorder Management

March 7 (Fri)17:50–18:40
Room14 (Kobe International Exhibition Hall, No.2 3F 3A Meeting Room)

Chair	Nobuhiko Seki	(Division of Medical Oncology, Department of Internal Medicine, Teikyo University School of Medicine)
Speaker	Hirotsugu Kenmotsu	(Department of Thoracic Oncology, Shizuoka Cancer Center)
	Yoshio Kiyohara	(Department of Dermatology, Shizuoka Cancer Center)
Co-host	Johnson & Johnson Innovative Medicine

Morning Seminar

Morning Seminar1

MoS1
Evolution of Colorectal Cancer Treatment and Use of Biomarkers: Realizing Personalized Medicine Based on DNA Methylation Status

March 7 (Fri)7:20–8:10
Room2 (Kobe Portopia Hotel, South Wing 1F Ohwada A)

Chair	Chikashi Ishioka	(JR Sendai Hospital)
Speaker	Eishi Baba	(Kyushu university hospital)
Co-host	Riken Genesis Co., Ltd. /Sysmex Corporation

Morning Seminar2

MoS2
New treatment strategy for Mantle Cell Lymphoma

March 7 (Fri)7:20–8:10
Room4 (Kobe Portopia Hotel, South Wing 1F Ohwada C)

Chair	Koji Izutsu	(Department of Hematology, National Cancer Center Hospital, Tokyo, Japan)
Speaker	Dai Maruyama	(Department of Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan)
Co-host	Nippon Shinyaku Co., Ltd.

Morning Seminar3

MoS3
Understanding the data of HR-positive HER2-negative advanced recurrent breast cancer ~clinical and statistical aspects~

March 7 (Fri)7:20–8:10
Room5 (Kobe Portopia Hotel, South Wing B1F Topaz)

Chair	Fumikata Hara	(Department of Breast Oncology, Aichi Cancer Center)
Speaker	Satoshi Morita	(Department of Biomedical Statistics and Bioinformatics, Kyoto University Graduate School of Medicine)
	Tetsuhiro Yoshinami	(Department of Breast and Endocrine Surgery, Graduate School of Medicine, Osaka University)
Co-host	Eli Lilly Japan K.K.

Morning Seminar4

MoS4
Utilization of liquid CGP for mCRC

March 7 (Fri)7:20–8:10
Room6 (Kobe Portopia Hotel, South Wing B1F Emerald)

Chair	Yu Sunakawa	(Department of Clinical Oncology, St. Marianna University School of Medicine)
Speaker	How we leverage liquid CGP test based on GOZILA study achievements.
	Yoshiaki Nakamura	(Translational Research Support Section, Translational Research Management Division, Clinical Research Support Office / Department of Gastrointestinal Oncology, National Cancer Center Hospital East)
	Clinical practice of cancer genome profiling test for mCRC
	Wataru Ichikawa	(Department of Medical Oncology, Showa University Fujigaoka Hospital)
Co-host	Guardant Health Japan

Morning Seminar5

MoS5
Evolving Treatment of Cervical Cancer: Advances at the Forefront and the Role of Multidisciplinary Collaboration

March 7 (Fri)7:20–8:10
Room7 (Kobe International Conference Center, B1/1F Main Hall)

Chair	Hidemichi Watari	(Department of Obstetrics and Gynecology, Hokkaido University Graduate School of Medicine, and Faculty of Medicine)
Speaker	Kazuhiro Takehara	(Department of Gynaecologic Oncology, National Hospital Organization Shikoku Cancer Center)
Co-host	Genmab KK, Medical Affairs

Morning Seminar6

MoS6
A Dialogue Between Medical Oncologists and Surgeons : The Current Status and Future of Gastric Cancer Treatment

March 7 (Fri)7:20–8:10
Room8 (Kobe International Conference Center, 3F International Conference Room)

Chair	Kei Muro	(Department of Clinical Oncology, Aichi Cancer Center Hospital)
Speaker	Eiji Oki	(Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University)
Co-host	AstraZeneca K.K. Medical

Morning Seminar7

MoS7
First-line drug therapy for esophageal cancer: What is the optimal treatment option for long-term survival?

March 7 (Fri)7:20–8:10
Room9 (Kobe International Conference Center, 4F 401+402)

Chair	Ken Kato	(National Cancer Center Hospital)
Speaker	Hisato Kawakami	(Department of Clinical Oncology, Graduate School of Medicine of Tohoku University)
Co-host	Bristol-Myers Squibb K.K. /ONO PHARMACEUTICAL CO., LTD.

Morning Seminar8

MoS8
Transforming Lives: Towards Excellence in Cancer Outcomes

March 7 (Fri)7:20–8:10
Room10 (Kobe International Conference Center, 5F 501)

Chair	Masaki Kaibori	(Department of Hepatobiliary Surgery, Kansai Medical University)
Speaker	Patient Blood Management in Hepatobiliary Surgery
	Masaki Kaibori	(Department of Hepatobiliary Surgery, Kansai Medical University)
	Iron Deficiency Anemia in Oncology: Challenges and Innovations in Diagnosis and Management
	Toshifumi Yamaguchi	(Osaka Medical and Pharmaceutical University Hospital Cancer Chemotherapy Center)
Co-host	ZERIA Pharmaceutical Co.,Ltd.

Morning Seminar9

MoS9
Lung Cancer Genetic Testing: Navigating Lung Cancer Genetic Testing Options

March 7 (Fri)7:20–8:10
Room11 (Kobe International Conference Center, 5F 502)

Chair	Kazuhiko Nakagawa	(Kindai University Faculty of Medicine)
Speaker	Masayuki Takeda	(Department of Oncology, Nara Medical University Hospital)
	Hironori Ninomiya	(Department of Pathology, The Cancer Institute Hospital Of JFCR)
Co-host	Thermo Fisher Scientific

Morning Seminar10

MoS10
Comparing Data among Different Trials: Network Meta Analysis and Matching Adjusted Indirect Comparison

March 7 (Fri)7:20–8:10
Room12 (Kobe International Conference Center, 5F 504+505)

Chair	Ritsuro Suzuki	(Department of Hematology and Oncology, Shimane University School of Medicine)
Speaker	Ayumi Shintani	(Department of Medical Statistics, Graduate School of Medicine, Osaka Metropolitan University)
Co-host	BeiGene Japan GK

Morning Seminar11

MoS11
Considering Optimal Treatment for Elderly Lung Cancer Patients

March 7 (Fri)7:20–8:10
Room14 (Kobe International Exhibition Hall, No.2 3F 3A Meeting Room)

Chair	Masahiro Seike	(Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School.)
Speaker	Making geriatric assessment more accessible: No more confusion about SDM or treatment decisions!
	Yukari Tsubata	(Department of Respirology,Graduate School of Medicine, Gifu University)
	The optimal/personalized pharmacotherapy for elderly patients in non-small cell lung cancer
	Yusuke Okuma	(Department of Thoracic Oncology, National Cancer Center Hospital)
Co-host	CHUGAI PHARMACEUTICAL CO., LTD.

Morning Seminar12

MoS12
The cutting edge of endoscopic treatment for pancreatic and biliary cancer ~from the viewpoint of Onco-endoscopist~

March 8 (Sat)7:30–8:20
Room2 (Kobe Portopia Hotel, South Wing 1F Ohwada A)

Chair	Susumu Hijioka	(Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital)
Speaker	Kei Saito	(Nihon University School of Medicine Division of Gastroenterology and Hepatology, Department of Internal Medicine)
	Naminatsu Takahara	(Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo)
Co-host	Gadelius Medical K.K.

Morning Seminar13

MoS13
Consider infectious disease prevention in cancer patients

March 8 (Sat)7:30–8:20
Room4 (Kobe Portopia Hotel, South Wing 1F Ohwada C)

Chair	Kei Muro	(Department of Clinical Oncology, Aichi Cancer Center Hospital)
Speaker	Vaccines recommended for cancer patients
	Keiji Okinaka	(National Cancer Center Hospital East Division of Infectious Diseases National Cancer Center Hospital Division of Hematopoietic Stem Cell Transplantation)
	The significance of vaccination against shingles in patients with solid tumors
	Yoshito Komatsu	(Hokkaido University Hospital Tumor Center Chemotherapy Department /Cancer Board Department)
Co-host	GlaxoSmithKline K.K.

Morning Seminar14

MoS14
Drug Loss -Is it really drug loss? What should medical institutions do?-

March 8 (Sat)7:30–8:20
Room5 (Kobe Portopia Hotel, South Wing B1F Topaz)

Chair	Toshihiko Doi	(National Cancer Center Hospital East)
Speaker	Noboru Yamamoto	(National Cancer Center Hospital)
Co-host	IQVIA Services Japan G.K.

Morning Seminar15

MoS15
New treatment strategy for hormone receptor positive HER2 negative breast cancer - how to use ADC in Clinical Practice -

March 8 (Sat)7:30–8:20
Room6 (Kobe Portopia Hotel, South Wing B1F Emerald)

Chair	Hiroji Iwata	(Nagoya City University, Graduate School of Medical Sciences, Department of Advanced Clinical Research and Development(affiliated with Department of Medical Research and Developmental Strategy))
Speaker	Fumikata Hara	(Department of Breast Oncology, Aichi Cancer Center Hospital)
Co-host	DAIICHI SANKYO COMPANY, LIMITED

Morning Seminar16

MoS16
Diagnosis and treatment of cancer of unknown primary

March 8 (Sat)7:30–8:20
Room7 (Kobe International Conference Center, B1/1F Main Hall)

Chair	Kan Yonemori	(Department of Medical Oncology, National Cancer Center Hospital)
Speaker	Kazuki Sudo	(Department of Medical Oncology, National Cancer Center Hospital)
Co-host	Bristol-Myers Squibb K.K. /ONO PHARMACEUTICAL CO., LTD.

Morning Seminar17

MoS17
Basics and clinical activity of ADC - Trastuzumab Deruxtecan -

March 8 (Sat)7:30–8:20
Room8 (Kobe International Conference Center, 3F International Conference Room)

Chair	Makoto Nishio	(Department of Thoracic Medical Oncology, The Cancer Institute Hospital of JFCR)
Speaker	Hidehito Horinouchi	(Department of Thoracic Oncology National Cancer Center Hospital)
Co-host	DAIICHI SANKYO COMPANY, LIMITED

Morning Seminar18

MoS18
New paradigm for R/R Follicular Lymphoma ~ Bispecific antibody ~

March 8 (Sat)7:30–8:20
Room9 (Kobe International Conference Center, 4F 401+402)

Chair	Eisei Kondo	(Department of Hematology, Kawasaki Medical School)
Speaker	Nobuhiro Kanemura	(Department of Hematology and Infectious Disease, Gifu University Hospital)
Co-host	CHUGAI PHARMACEUTICAL CO., LTD.

Morning Seminar19

MoS19
New Treatment for SCLC: Safety and Efficacy of IMDELLTRA

March 8 (Sat)7:30–8:20
Room10 (Kobe International Conference Center, 5F 501)

Chair	Miyako Satouchi	(Hyogo Cancer Center)
Speaker	Hiroki Izumi	(National Cancer Center Hospital East)
Co-host	Amgen K.K.

Morning Seminar20

MoS20
Comprehensive genomic profiling test

March 8 (Sat)7:30–8:20
Room11 (Kobe International Conference Center, 5F 502)

Chair	Yoshinaga Okugawa	(Department of Genomic Medicine, Mie University Hospital)
Speaker	The Practice of Cancer Genomic Medicine for Gastrointestinal Cancers~Expectations for RNA-seq
	Nobumi Suzuki	(Graduate School of Medicine, Department of Gastroenterology, The University of Tokyo)
	How to use the diversified Comprehensive Genomic Profiling
	Masashi Kanai	(Department of Clinical Oncology, Kansai Medical University Hospital)
Co-host	KONICA MINOLTA REALM, INC

Morning Seminar21

MoS21
Current status of CGP and introduction of new panel

March 8 (Sat)7:30–8:20
Room12 (Kobe International Conference Center, 5F 504+505)

Chair	Manabu Muto	(Graduate School of Medicine and faculty of Medicine, Kyoto University)
Speaker	Kohei Nakamura	(Center for Cancer Genomics, Keio University School of Medicine)
Co-host	Illumina K.K.

Morning Seminar22

MoS22
New treatment options for non-small cell lung cancer

March 8 (Sat)7:30–8:20
Room13 (Kobe International Exhibition Hall, No.2 2F 2A Meeting Room)

Chair	Hidetoshi Hayashi	(Department of Medical Oncology, Kindai University, Faculty of Medicine)
Speaker	Ticiana Leal	(Department of Hematology & Oncology, Thoracic Medical Oncology Winship Cancer Institute Emory University)
Co-host	Novocure K.K.

Morning Seminar23

MoS23
Treatment Strategy for EGFR m+ Lung Cancer: Tailoring Treatment Approaches Based on Mutation Subtype

March 8 (Sat)7:30–8:20
Room14 (Kobe International Exhibition Hall, No.2 3F 3A Meeting Room)

Chair	Takayasu Kurata	(Department of Thoracic Oncology, Kansai Medical University)
Speaker	Toshiyuki Kozuki	(Department of Respiratory Medicine and Allergology, Kochi University School of Medicine)
Co-host	Nippon Boehringer Ingelheim Co., Ltd.